MDS Nordion begins medical isotope shipments
82144
Canada's MDS Nordion started shipping  medical isotopes on Wednesday after a prolonged shutdown of a  nuclear reactor at Chalk River, Ontario, disrupted the supply  of isotopes to health facilities around the world.
536698
EU approval opens new markets for the cancer drug that could edge out the competition by lowering overall medical costs.
131375
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Sep. 7--It took five years, but Cardinal Health has received regulatory approval to start making drugs at its North Raleigh plant.
181860
Platforms have the potential to develop multiple drugs for a company.
700311
Biopharmaceutical company Medarex Inc. said Monday that it reached a special protocol assessment agreement with the Food and Drug Administration to start a late-stage clinical trial for its MDX-010 drug as a combination treatment for melanoma patients.
438501
Here's what a newly approved drug looks like.
127123
Safend, an international provider of endpoint i
489479
Millipore Corp. , a leading supplier of equipment to the drug industry, plans today to open a $50 million research center in Bedford , the centerpiece of a new effort to improve the costly process of making biotechnology drugs.
407294
The biotech company announces new drug delays.
644497
Scientists have moved closer to being able to use human stem cells to manufacture blood.
145826
American Oriental Bioengineering makes an acquisition.
388516
Renovis continues development of its preclinical compounds.
665690
The developing biopharmaceutical company announces a share offering.
667689
The biotech firm advances to next stage of clinical studies in stem cell research.
139237
Secure Freight Initiative will see cargo scanned for nuclear and radiological threats before it sets off for the U.S.
552279
The Canadian government is rushing through legislation to reopen a nuclear reactor that produces most of the worldâs supply of a medically important diagnostic isotope.
420195
Medarex's lead drug gets an important yet expected designation from the FDA.